Tag: Phillip Scheinberg

Novartis’ Promacta bags FDA approval for first-line severe aplastic anemia

pharmanewsdaily- November 19, 2018

Promacta FDA approval : The US Food and Drug Administration (FDA) has approved a label expansion for Novartis’ Promacta (eltrombopag) to cover the treatment of ... Read More